Clinical Trial Update: WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib

View source ↗

Summary

This clinical trial update describes using whole-body diffusion-weighted imaging to predict early response to regorafenib in patients with advanced/metastatic g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Gastrointestinal Stromal Tumors | Status: COMPLETED